CorMedix
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of CorMedix generated cash of -$38,409,480, which is less than the previous year. Cash used in financing activities reached the amount of $55,916,804 last year. Net change in cash is therefore $448,447.
Cash Flow
| 2014 | -6.32M | -25.40K | 8.35M |
|---|---|---|---|
| 2015 | -12.52M | -23.60M | 43.62M |
| 2016 | -22.26M | 11.41M | 7.09M |
| 2017 | -28.58M | 10.35M | 20.52M |
| 2018 | -23.70M | 1.55M | 29.39M |
| 2019 | -15.05M | -12.02M | 25.80M |
| 2020 | -21.96M | 7.42M | 40.09M |
| 2021 | -21.15M | -9.13M | 41.75M |
| 2022 | -24.35M | -3.70M | 17.89M |
| 2023 | -38.40M | -17.06M | 55.91M |
CRMD Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 43.37M | 53.55M | 42.09M | 16.52M | 17.79M | 10.37M | 8.06M | 11.81M | 4.33M | 2.37M |
Operating activities | ||||||||||
Net income | -46.33M | -29.70M | -28.21M | -22.02M | -16.43M | -26.82M | -33.00M | -24.64M | -18.18M | -20.45M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 70.75K | 84.61K | 61.89K | 127.96K | 73.28K | 74.21K | 36.88K | 25.59K | 15.07K | 15.07K |
Stock-based compensation expense | 5.49M | 4.06M | 5.04M | 2.49M | 2.43M | 0 | 1.65M | 1.33M | 3.22M | 2.16M |
| Deferred income tax benefit | 5.49M | 4.06M | 5.04M | 2.49M | 2.43M | 0 | 1.65M | 1.33M | 3.22M | 2.16M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 42.14K | -44.08K | -3.08K | 10.63K | 51.98K | -47.59K | 307.77K | -248.18K | -85.41K |
Inventories | 0 | 3.00K | 145.45K | 149.59K | 59.28K | 165.67K | -100.46K | 79.83K | -38.54K | -558.00K |
Accounts payable | 0 | -6.56K | 1.08M | 103.33K | -1.56M | 782.06K | 157.52K | -63.58K | 825.10K | 8.05K |
Cash generated by operating activities | -38.40M | -24.35M | -21.15M | -21.96M | -15.05M | -23.70M | -28.58M | -22.26M | -12.52M | -6.32M |
Investing activities | ||||||||||
Purchases Of Investments | -77.08M | -31.14M | -15.28M | -8.54M | -14.10M | 0 | -13.07M | 0 | -23.59M | 0 |
Investments In Property Plant And Equipment | -327.3K | -219.36K | -1.42M | -112.63K | -36.57K | -48.89K | -151.98K | -58.72K | -15.44K | -25.40K |
Acquisitions Net | 0 | 3.70M | 9.13M | -7.53M | 11.98M | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -17.06M | -3.70M | -9.13M | 7.42M | -12.02M | 1.55M | 10.35M | 11.41M | -23.60M | -25.40K |
Financing activities | ||||||||||
Common Stock Issued | 55.82M | 17.76M | 41.45M | 39.68M | 15.23M | 21.96M | 18.64M | 6.22M | 28.45M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | -7.39M | 0 | 0 | 0 | 0 |
Cash used in financing activities | 55.91M | 17.89M | 41.75M | 40.09M | 25.80M | 29.39M | 20.52M | 7.09M | 43.62M | 8.35M |
Net Change In Cash | 448.44K | -10.17M | 11.45M | 25.57M | -1.27M | 7.24M | 2.31M | -3.75M | 7.47M | 1.96M |
Cash at end of period | 43.82M | 43.37M | 53.55M | 42.09M | 16.52M | 17.62M | 10.37M | 8.06M | 11.81M | 4.33M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |